CJ ENM Injects Additional 200 Billion KRW into CJ Live City Amid K-Culture Valley Project Setback

Reporter Kim Jisun / approved : 2025-01-23 07:09:27
  • -
  • +
  • 인쇄

Photo = Yonhap news

 

[Alpha Biz= Kim Jisun] CJ ENM is injecting an additional 200 billion KRW into CJ Live City, which has faced setbacks with its K-Culture Valley complex development project.


According to a filing with the electronic disclosure system on Wednesday, CJ Live City announced that it had decided to issue new shares worth 200 billion KRW through a third-party allocation. The largest shareholder, CJ ENM, will acquire 100% of the newly issued shares. This follows a similar capital injection of 98 billion KRW from CJ ENM in September of last year.


CJ ENM established CJ Live City in late 2015 by investing a 90% stake. The project, a large-scale national initiative in collaboration with Gyeonggi Province, aimed to build a 100,000 pyeong (326,400㎡) K-content experience complex in the Janghang-dong area of Ilsan, Goyang. However, the project was halted in July of last year.


The problem lies in the fact that CJ Group had invested over 7 trillion KRW into the project, and by the end of 2023, CJ Live City's outstanding loans amounted to 5.999 trillion KRW, creating a heavy repayment burden. The previous capital injection of 98 billion KRW from CJ ENM was used to repay maturing debt.


Despite a 10.8% year-on-year increase in sales to 3.4434 trillion KRW in the third quarter of last year, CJ ENM recorded a net loss of 556.2 billion KRW. Its cash and cash equivalents stood at 782.7 billion KRW, down 24.2% from 1.0326 trillion KRW at the end of 2023.

 

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

SK hynix and Naver Cloud Join Forces to Accelerate Next-Generation AI Memory Solutions2025.09.11
HD Hyundai Heavy Industries Strike Clash Leaves Union Member Injured2025.09.11
Chartered Korean Air Flight to Repatriate Over 300 Koreans Detained at Georgia Battery Plant; Industry Fears Multi-Billion Losses Amid Construction Halt2025.09.11
Chong Kun Dang Chairman Transfers Entire Stake in Kyungbo Pharmaceutical to Children, Expands IT Subsidiary Portfolio2025.09.11
Harim Holdings to Acquire Entire Harim USA Stake from Subsidiary Farmsco2025.09.11
뉴스댓글 >